Checking ARQT unusual options activity helps you spot when traders are making outsized bets on Arcutis Biotherapeutics Inc before the broader market catches on. Arcutis Biotherapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ARQT unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ARQT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ARQT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ARQT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata.
The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Catalysts rarely arrive without a footprint, and ARQT unusual options activity is often where that footprint shows up first. Our scanner tracks Arcutis Biotherapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ARQT unusual options volume on the call side or chasing put sweeps, Arcutis Biotherapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
